Document Detail


Okadaic acid protects human neuroblastoma SH-SY5Y cells from 1-methyl-4-phenylpyridinium ion-induced apoptosis.
MedLine Citation:
PMID:  19000740     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
1-methyl-4-phenylpyridinium ion (MPP(+)) has been shown to selectively inhibit mitochondrial function and induce a parkinsonism-like syndrome. MPP(+) stimulates the production of reactive oxygen species (ROS) and induces cell death in vitro. In this study, we investigated the protective effects of okadaic acid on MPP(+)-induced cell death in SH-SY5Y neuroblastoma cells. We found that MPP(+)-induced apoptosis and -ROS generation were blocked by okadaic acid. MPP(+)-mediated activation of AKT was also inhibited by okadaic acid. Taken together, these results demonstrate that okadaic acid protects against MPP(+)-induced apoptosis by blocking ROS stimulation and ROS-mediated signaling pathways in SH-SY5Y cells. These data indicated that okadaic acid could provide a therapeutic strategy for the treatment of neurodegenerative diseases including Parkinson's disease.
Authors:
Kook-Hee Ahn; Young-Sun Kim; Seon-Ye Kim; Youngbuhm Huh; Chan Park; Joo-Won Jeong
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2008-11-05
Journal Detail:
Title:  Neuroscience letters     Volume:  449     ISSN:  0304-3940     ISO Abbreviation:  Neurosci. Lett.     Publication Date:  2009 Jan 
Date Detail:
Created Date:  2008-12-08     Completed Date:  2009-03-20     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  7600130     Medline TA:  Neurosci Lett     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  93-7     Citation Subset:  IM    
Affiliation:
Department of Anatomy and Neurobiology, Biomedical Science Institute, School of Medicine, Kyung Hee University, Seoul, Republic of Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
1-Methyl-4-phenylpyridinium / antagonists & inhibitors
Apoptosis / drug effects*,  physiology
Cell Line, Tumor
Cytoprotection / drug effects,  physiology
Enzyme Inhibitors / pharmacology
Herbicides / antagonists & inhibitors
Humans
Nerve Degeneration / drug therapy*,  metabolism,  physiopathology
Neuroblastoma
Neurons / drug effects*,  metabolism,  pathology
Neuroprotective Agents / pharmacology
Okadaic Acid / pharmacology*
Oxidative Stress / drug effects*,  physiology
Parkinson Disease / drug therapy*,  metabolism,  physiopathology
Protein Phosphatase 2 / antagonists & inhibitors,  metabolism
Proto-Oncogene Proteins c-akt / drug effects,  metabolism
Reactive Oxygen Species / antagonists & inhibitors,  metabolism
Signal Transduction / drug effects,  physiology
Chemical
Reg. No./Substance:
0/Enzyme Inhibitors; 0/Herbicides; 0/Neuroprotective Agents; 0/Reactive Oxygen Species; 48134-75-4/1-Methyl-4-phenylpyridinium; 78111-17-8/Okadaic Acid; EC 2.7.11.1/Proto-Oncogene Proteins c-akt; EC 3.1.3.16/Protein Phosphatase 2

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Brain-computer interface: changes in performance using virtual reality techniques.
Next Document:  NDE1 and NDEL1: multimerisation, alternate splicing and DISC1 interaction.